التفاصيل البيبلوغرافية
العنوان: |
Barriers to statin use in the Philippines. |
المؤلفون: |
Feliciano KT; St Luke's Medical Center College of Medicine, William H Quasha Memorial, 1112 Quezon City, Philippines., Dychiao RGK; College of Medicine, University of the Philippines, Manila, Philippines., Eala MAB; College of Medicine, University of the Philippines, Manila, Philippines., Paguio JA; Department of Internal Medicine, Albert Einstein Medical Center, PA, USA., Guinto RR; St Luke's Medical Center College of Medicine, William H Quasha Memorial, 1112 Quezon City, Philippines; Sunway Centre for Planetary Health, Sunway University, Petaling Jaya, Malaysia. Electronic address: guinto.rl.f@slmc-cm.edu.ph. |
المصدر: |
The Lancet. Global health [Lancet Glob Health] 2022 Jun; Vol. 10 (6), pp. e796. |
نوع المنشور: |
Letter; Comment |
اللغة: |
English |
بيانات الدورية: |
Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE |
أسماء مطبوعة: |
Original Publication: [England] : Elsevier Ltd. 2013- |
مواضيع طبية MeSH: |
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use, Humans ; Philippines/epidemiology |
مستخلص: |
Competing Interests: We declare no competing interests |
التعليقات: |
Comment on: Lancet Glob Health. 2022 Mar;10(3):e369-e379. (PMID: 35180420) |
المشرفين على المادة: |
0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) |
تواريخ الأحداث: |
Date Created: 20220513 Date Completed: 20220517 Latest Revision: 20220615 |
رمز التحديث: |
20231215 |
DOI: |
10.1016/S2214-109X(22)00201-7 |
PMID: |
35561717 |
قاعدة البيانات: |
MEDLINE |